Logo image
Analogs of the anti-malaria drug mefloquine have broad-spectrum antifungal activity and are efficacious in a model of disseminated Candida auris infection
Journal article   Peer reviewed

Analogs of the anti-malaria drug mefloquine have broad-spectrum antifungal activity and are efficacious in a model of disseminated Candida auris infection

Soumitra Guin, Marhiah C. Montoya, Xiaoyu Wang, Robert Zarnowski, David R. Andes, Marvin J. Meyers, Noelle S. Williams and Damian J. Krysan
Antimicrobial agents and chemotherapy, Vol.68(11), e01301-24
11/06/2024
DOI: 10.1128/aac.01301-24
PMCID: PMC11539235
PMID: 39365066
url
https://pmc.ncbi.nlm.nih.gov/articles/PMC11539235/pdf/aac.01301-24.pdfView
Open Access

Abstract

Only three classes of antifungal drugs are currently in clinical use. Here, we report that derivatives of the malarial drug mefloquine have broad-spectrum antifungal activity including difficult-to-treat molds and endemic fungi. Pharmacokinetic and efficacy studies of NSC-4377 indicate that it penetrates the central nervous system and is active against Candida auris in vivo. These data strongly support the further development of mefloquine analogs as a potentially new class of antifungal molecules.
Antimicrobial Chemotherapy Experimental Therapeutics

Details

Metrics

Logo image